Delivery Order SPE2DB20D2104-SPE2DB22FT51A

Award Date 8/3/22
Potential Completion Date 8/4/22
Potential Value $1.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of PRADAXA 150 MG CAPSULE UU 60S to the U.S. government. The contract, valued at $2,589.99, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to various federal agencies, including the Department of Defense (DoD) and Veterans Affairs (VA). The contract is a Delivery Order with a Firm Fixed Price pricing type, with a completion date of May 29, 2024....
This federal contract award is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,206.55 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 29, 2024 with a completion date of December 2, 2024. The contract is a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen maintains a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,947.96, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product, with a period of performance through March 6, 2023. The contract is a delivery order issued under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running...
The U.S. Defense Logistics Agency (DLA) awarded a $37,269.81 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division. The order is for the supply of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product, with a completion date of September 4, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
This federal contract award is for the delivery of PRADAXA 75 MG CAPSULE UD 60S, a prescription medication, to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,218.98 and is a firm fixed-price delivery order. It has an ultimate completion date of July 16, 2024. Amerisourcebergen holds a larger Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,933.40, is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a prescription medication. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award is for the delivery of Pradaxa 150 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,554,756,127 units of the drug PRADAXA 150 MG CAPSULE. The contract has a firm fixed price ceiling value of $1,334.33 and an ultimate completion date of September 14, 2021. The contract is a delivery order without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PRADAXA 150 MG CAPSULE in quantities of 60s, with a ceiling value of $1,314.36. The order has a firm fixed price, with a completion date of July 25, 2022. This contract is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $3,278.72, is for the delivery of PRADAXA 150 mg capsules. The contract is a firm fixed-price Delivery Order, with an ultimate completion date of September 30, 2022. This contract award is not associated with a set-aside program. The contract is part of a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB22FT51A
    Delivery Order

This federal contract award is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,595.26, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on August 3, 2022 with an ultimate completion date of August 4, 2022.

The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 31, 2025. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:46 AM